Ebook

Cell & Gene Therapy Outsourcing Trends

Cell and gene therapies represent the next-generation of therapeutics.

Related CONTENT

07.14.21

The New Wave of Innovation
Cell and gene therapies represent the new wave of innovation in the life sciences industry.
Read More >>

Allogeneic T-Cell Therapies
Efficient commercial manufacturing readiness using “Manufacturing by Design” methodology.
Read More >>

New Supply Chain Considerations in Response to Covid-19
Cell & gene therapy companies have faced unique challenges due to the nature of their therapies, this is especially true for autologous cell therapies.
Read More >>

The Future is...Therapeutic
As cell and gene therapies rise, so too does outsourcing.
Read More >>

Suggested For You

Lonza Further Invests in Drug Product Manufacturing Capabilities

Lonza Further Invests in Drug Product Manufacturing Capabilities

First Patient is Dosed with Triumvira

First Patient is Dosed with Triumvira's Investigational TAC-T Cell Adoptive Immunotherapy

Oxford Bio Advances Boehringer Oncology Candidate

Oxford Bio Advances Boehringer Oncology Candidate

Rentschler Biopharma Appoints Dr. Christian Schetter as Chief Scientific Officer

Rentschler Biopharma Appoints Dr. Christian Schetter as Chief Scientific Officer

Everest Medicines, Sinovent, SinoMab Enter Global BTK Inhibitor Mfg. Pact

Everest Medicines, Sinovent, SinoMab Enter Global BTK Inhibitor Mfg. Pact

Lilly’s Antibody Treatment Gets EUA for Post-Exposure COVID Prevention

Lilly’s Antibody Treatment Gets EUA for Post-Exposure COVID Prevention

Clean Cells Expands Bioproduction Capabilities

Clean Cells Expands Bioproduction Capabilities

Symbiosis Completes Successful MHRA Audit

Symbiosis Completes Successful MHRA Audit

Catalent Signs Commercial Supply Agreement with Phathom Pharmaceuticals

Catalent Signs Commercial Supply Agreement with Phathom Pharmaceuticals

Diadem Biotherapeutics Awarded the First Amgen Golden Ticket

Diadem Biotherapeutics Awarded the First Amgen Golden Ticket

U.S. Govt. to Purchase Additional Doses of REGEN-COV Antibody Cocktail

U.S. Govt. to Purchase Additional Doses of REGEN-COV Antibody Cocktail

U.S. Govt. Purchases Additional Doses of Lilly

U.S. Govt. Purchases Additional Doses of Lilly's Antibody Therapies for COVID

Aurion Biotech Makes Strategic Investments in Manufacturing

Aurion Biotech Makes Strategic Investments in Manufacturing

Lakes BioScience Signs Agreement with Cytvia

Lakes BioScience Signs Agreement with Cytvia

Eliminating Endotoxins – Reagent Quality Testing for Cell and Gene Therapies

Eliminating Endotoxins – Reagent Quality Testing for Cell and Gene Therapies

Related Content

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Lonza Further Invests in Drug Product Manufacturing Capabilities

New filling line to process various modalities, including monoclonal antibodies, bioconjugates, viral vectors, and other gene therapy products.
09.22.21
Breaking News | Clinical Trials

First Patient is Dosed with Triumvira's Investigational TAC-T Cell Adoptive Immunotherapy

TAC01-HER2 was developed for the treatment of HER2-overexpressing cancers.
09.21.21
Breaking News | Collaborations & Alliances | Drug Development | Industry News

Oxford Bio Advances Boehringer Oncology Candidate

Receives another milestone payment from Boehringer Ingelheim for progressing a second oncology drug candidate (BI 765049) into the clinic.
09.20.21
Breaking News | Promotions & Moves

Rentschler Biopharma Appoints Dr. Christian Schetter as Chief Scientific Officer

Schetter has a proven track record across the entire biopharmaceutical value chain.
09.20.21
Breaking News | cGMP Manufacture | Drug Development | Industry News

Everest Medicines, Sinovent, SinoMab Enter Global BTK Inhibitor Mfg. Pact

To develop, produce and commercialize XNW1011, a covalent reversible BTK inhibitor, globally for the treatment of renal diseases.
09.17.21